Form 4: Omega Healthcare Investors Director Receives Stock Grant

Sentiment:

Statement of Changes in Beneficial Ownership


Omega Healthcare Investors, Inc. reports a restricted stock grant to Director Burke W. Whitman as part of compensation.

Summary

  • Burke W. Whitman, a Director at Omega Healthcare Investors, Inc. (OHI), received a restricted stock grant on June 5, 2026.
  • The grant consists of 3,778 shares of common stock.
  • This award is part of director compensation and is valued at approximately $43.67 per share.
  • The restricted stock will vest on the date of the Company's 2027 Annual Meeting of Shareholders, approximately one year from the grant date.
  • Upon vesting, the shares will convert to common stock on a one-for-one basis.
  • Following the transaction, Whitman beneficially owns 47,931 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard director compensation event rather than a significant financial or strategic development.

Positives

  • Director compensation is being utilized through stock grants, aligning director interests with shareholder value.
  • The grant is a clear mechanism for rewarding director service.

Future Outlook

The restricted stock grant is set to vest on the date of the Company's 2027 Annual Meeting of Shareholders, approximately one year from the grant date, at which point it will convert to common stock.

Industry Context

StockSavvy.ai notes that the use of restricted stock grants for director compensation is a common practice within the healthcare REIT industry, aiming to align executive and director incentives with long-term shareholder value creation.

Stakeholder Impact

  • Shareholders: The grant aligns director interests with long-term shareholder value, as the vesting is tied to future company performance and share price appreciation.

Next Steps

  • The restricted stock grant will vest on the date of the Company's 2027 Annual Meeting of Shareholders.
  • Upon vesting, the restricted stock will convert to common stock on a one-for-one basis.

Key Dates

DateDescription
02/09/2022Date of execution for the Power of Attorney document.
06/05/2026Date of the restricted stock grant transaction.
06/09/2026Date the Form 4 filing was signed by the attorney-in-fact.
2027Approximate date of the Company's 2027 Annual Meeting of Shareholders, when the restricted stock grant will vest.

Keywords

Omega Healthcare Investors, OHI, Form 4, Director Compensation, Restricted Stock Grant, Beneficial Ownership, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.